A case of perifolliculitis capitis abscedens et suffodiens and acne conglobata effectively treated with a tumor necrosis factor α inhibitor
https://doi.org/10.4081/dr.2023.9699
HTML: 4
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Not available
Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015; 29:619-44. DOI: https://doi.org/10.1111/jdv.12966
Wu KK, Dao H Jr. Off-label dermatologic uses of IL-17 inhibitors. J Dermatol Treat .2020; 9:1-7. DOI: https://doi.org/10.1080/09546634.2020.1737638
Melnik BC, John SM, Chen W, Plewig G. T helper 17 cell/regulatory T-cell imbalance in hidradenitis suppurativa/acne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities. Br J Dermatol. 2018; 179:260-72. DOI: https://doi.org/10.1111/bjd.16561
Mansouri Y, Martin-Clavijo A, Newsome P, Kaur MR. Dissecting cellulitis of the scalp treated with tumour necrosis factor-α inhibitors: experience with two agents. Br J Dermatol. 2016; 174:916-8. DOI: https://doi.org/10.1111/bjd.14269
Kamil MAA, Chandran NS, Sulistyaningrum SK, Rajagopalan M, et al. The Asia Pacific Hidradenitis Suppurativa (APHiS) foundation: promoting hidradenitis suppurativa research in the Asia Pacific. Int J Dermatol. 2020; 59:e289–90. DOI: https://doi.org/10.1111/ijd.14960
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
